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1  |  INTRODUC TION
The COVID- 19 pandemic has radically changed the management of 
cancer patients (Archer et al., 2020; Tsamakis et al., 2020), a popu-
lation with intrinsically higher lethality from SARS- Cov- 2 infection 
(Pinato et al., 2020). Social distancing, quarantine and lockdown 
measures have limited access not only to clinical care (Neal et al., 
2020) but also to supportive and psychosocial care (Archer et al., 
2020). The social repercussions of such measures are unlikely to be 
short- lived (Young et al., 2020) and include a vast range of additional 
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Abstract
Objectives: The COVID- 19 pandemic is having considerable impact on cancer care, 
including restricted access to hospital- based care, treatment and psychosocial sup-
port.	We	investigated	the	impact	on	unmet	needs	and	psychosocial	well-	being.
Methods: One hundred and forty four participants (77% female), including people 




Results: Half	 of	 our	 patient	 respondents	 reported	 unexpected	 changes	 to	 treat-
ment following pandemic onset, with widespread confusion about their longer- term 
consequences. Although overall need levels have not increased, specific needs have 
changed in prominence. People with cancer reported significantly reduced anxiety 
(p = 0.049) and improved quality of life (p = 0.032) following pandemic onset, but 
support network participants reported reduced quality of life (p = 0.009), and non- 
significantly elevated anxiety, stress and depression.
Conclusion: Psychological well- being of people with cancer has not been detrimen-
tally affected by pandemic onset. Reliance on home- based support to compensate 
for the lost availability of structured healthcare pathways may, however, explain sig-
nificant and detrimental effects on the well- being and quality of life of people in their 
support and informal care networks.
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stressors (e.g. caring responsibilities and financial pressures) for both 
patients and their informal support networks (Nekhlyudoc et al., 
2020). Although clinical and psychosocial support are available via 
telehealth (Archer et al., 2020) and remote consultation, these tech-
nologies may not meet all patient needs effectively and require fur-
ther evidence about their accessibility, acceptability and influence 
on patient outcomes (Neal et al., 2020).
Psychosocially, COVID- 19 is thought to contribute to uncertainty, 
isolation and loneliness in cancer patients (Nekhlyudov et al., 2020; 
Tsamakis et al., 2020), and treatment delays correlate with exacer-
bated fear of progression, anxiety and depression (Chen et al., 2020). 
However,	there	is	no	systematic	evidence	to	demonstrate	this	using	
patient- reported outcome data. In this UK- wide study, we hypothe-
sised that the pandemic resulted in changed unmet needs, increased 
distress	and	poorer	quality	of	life	(QoL),	in	people	affected	by	cancer.
2  |  METHODS
2.1  |  Participants and procedures
This prospectively planned, cross- sectional study compared two 
samples of participants, recruited at two time points: June/July 
2019 (pre- pandemic, n = 41) and June/July 2020 (during pandemic, 
n = 103). Eligible participants were people aged >16 years seeking 
cancer- related support (for their own diagnosis, or that of someone 
in	their	support	networks)	from	UK-	based	Maggie's	Cancer	Centres.
Ethical approval was first granted by the University of Chester 
Department	of	Psychology	Ethics	Committee	in	May	2019.	The	orig-
inal aim of this prospective study was to track the unmet needs of 
cancer survivors engaging with charity- based cancer support ser-
vices, and how these related to psychosocial well- being. A subse-
quent ethics amendment granted in April 2020 allowed us to add 
additional questions pertaining to COVID- 19 and to build in a sec-
ondary research question to reflect the impact of the onset of the 
COVID- 19 pandemic, as is reported in this paper.
The 2019 sample was recruited by an on- site researcher. 
Following	consent,	participants	completed	paper-	and-	pen	question-
naires. Because of social distancing, the 2020 sample was recruited 
through	the	Maggie's	Online	Centre	and	organisational-	based	social	
media adverts, with participants directed to a questionnaire hosted 
on JISC Online Surveys. Recruiting via social media has been demon-
strated an effective way of recruiting cancer survivors; however, the 
nature of social media means that it is impossible to provide an accu-
rate response rate as the baseline population rate is highly variable 
over	time	(Hulbert-	Williams	et	al.,	2019).
2.2  |  Measures
Participants self- reported demographic and clinical information. 
As primary study endpoints, we selected validated self- report 
questionnaires of psychosocial well- being. Patient unmet needs were 
assessed using the short form of the Supportive Care Needs Survey 
(SCNS-	SF34;	Boyes	et	al.,	2009),	a	34-	item	measure	assessing	unmet	
needs across five domains of care: health system and information; 
psychological; physical and daily living; patient care and support; and 
sexuality	needs.	The	SCNS-	SF34	has	been	validated	in	two	separate	
samples of adult cancer patients (N = 888 and N = 250, respectively), 
representing a range of cancer sites (Boyes et al., 2009). Support 
network unmet needs were assessed using the closely related 
Supportive Care Needs Survey— Partners and Caregivers (SCNS- 
P&C; Girgis et al., 2011), a 44- item measure of four domains of unmet 
needs: healthcare service needs; psychological and emotional needs; 
work and social needs; and information needs. The SCNS- P&C has 
previously been validated in a sample of 547 caregivers of patients 
living with colorectal, breast, prostate, lung, or head and neck can-
cer,	leukaemia,	non-	Hodgkin's	lymphoma	or	melanoma	(Girgis	et	al.,	
2011).	Higher	scores	on	both	versions	of	the	SCNS	indicate	greater	
unmet needs (Boyes et al., 2009; Girgis et al., 2011).
Patients'	QoL	was	assessed	using	the	Functional	Assessment	of	
Cancer	Therapy—	General	(FACT-	G;	Cella	et	al.,	1993),	a	33-	item	as-
sessment of physical, social/family, emotional and functional cancer- 
related	well-	being	over	the	previous	seven-	day	period.	The	FACT-	G	
has previously been validated in a sample of 545 patients with a 
range	of	cancer	diagnoses	(Cella	et	al.,	1993).	We	used	the	Caregiver	
Oncology	Quality	 of	 Life	 questionnaire	 (CarGOQoL;	Minaya	 et	 al.,	
2012)	 to	 assess	QoL	 in	 support	 network	participants.	 This	29-	item	
measure	indicates	ten	10	dimensions	of	QoL	including	psychological	
well- being; burden; relationship with health care; administration and 
finance; coping; physical well- being; self- esteem; leisure time; social 
support;	 and	private	 life.	 The	CarGOQoL	has	previously	 been	 vali-
dated	in	a	sample	of	837	caregivers	of	cancer	patients.	Higher	scores	
on	both	the	FACT-	G	and	CarGOQoL	indicate	greater	QoL.	Depression,	
anxiety and stress were assessed in both participants groups using 
the	21-	item	Depression,	Anxiety	and	Stress	Scales	(DASS;	Lovibond	
&	Lovibond,	1995)	(all	participants)	to	assess	anxiety,	depression	and	
stress. The 21- item DASS has previously been validated in a sample 
of	376	patients	with	cancer	of	various	sites	(Fox	et	al.,	2018).	Higher	
scores on the DASS indicate more severe depression, anxiety and 
stress, respectively.
The patient sample recruit in 2020 only answered additional 
questions about the perceived impact of COVID- 19 on cancer care 
and treatment.
2.3  |  Statistical analysis
Variables were calculated following standard test scoring guide-
lines.	Missing	data	were	not	imputed.	We	report	difference	in	mean	
unmet need scores at domain level, and change in mean ranking of 
individual	needs	items.	We	used	ANOVA	with	Cohen's	d	effect	size	
estimates and Reliable Change Indices (RCIs) to explore differences 
in	distress	and	QoL.
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TA B L E  1 Baseline	socio-	demographic	and	clinical	profile	of	the	sample
Cancer patients Support Network
2019 (n = 29) 2020 (n = 92) p 2019 (n = 12) 2020 (n = 11) p
Gender
Male 2 (6.9%) 21 (22.8%) 0.071 6 (50.0%) 1 (9.1%) 0.069
Female 25 (86.2%) 70 (76.1%) 6 (50.0%) 10 (90.0%)
Missing 2 (3.9%) 1 (1.1%)
Age (years)
Mean 57.63 65.26 0.503 60.04 45.67 0.010
S.D. 11.88 9.37 10.88 14.76
Country
England 23 (79.3%) 40 (43.5%) 0.018 8 (66.7%) 6 (54.5%) 0.485
Scotland 6 (20.7%) 33 (35.9%) 4 (33.3%) 3 (27.3%)
Wales 6 (6.5%) 2 (18.2%)
Missing 13 (14.1%)
Cancer Type
Brain/CNS 1 (3.4%) 4 (4.3%) 0.074 2 (16.7%) 1 (9.1%) 0.909
Breast 17 (58.6%) 38 (41.3%) 1 (8.3%) 2 (18.2%)
Gynaecological 3 (10.3%) 3 (3.3%) 1 (8.3%)
Haematological 1 (3.4%) 9 (9.8%) 1 (8.3%) 2 (18.2%)
Head	&	Neck 1 (3.4%) 3 (3.3%)
Lower	GI	/	Bowel 1 (3.4%) 6 (6.5%) 1 (8.3%) 1 (9.1%)
Lung 4 (4.3%)
Pancreatic 1 (3.4%) 1 (8.3%)
Prostate 2 (6.9%) 11 (12.0%) 2 (16.7%) 1 (9.1%)
Sarcoma 2 (2.2%) 2 (18.2%)
Upper GI 2 (2.2%) 1 (9.1%)
Urology / Bladder 2 (2.2%) 2 (16.7%)
Unknown Primary 1 (9.1%)
Other 2 (6.9%) 7 (7.6%) 1 (8.3%)
Missing 1 (1.1)
Time since diagnosis
<2 months 18 (62.1%) 1 (1.1%) <0.001 8 (66.7%) 1 (9.1%) 0.046
2– 12 months 3 (10.3%) 18 (19.6%) 1 (8.3%) 3 (27.3%)
13– 24 months 4 (13.85) 19 (20.7%) 1 (8.3%) 1 (9.1%)
2– 5 years 3 (10.3%) 35 (38.0%) 2 (16.7%) 6 (54.5%)
<5 years 18 (19.6%)
Missing 1 (3.4%) 1 (1.1%)
Treatment Phase
Active Treatment 15 (51.7%) 25 (27.2%) 0.027 7 (58.3%) 4 (36.4%) 0.491
Completed 8 (27.6%) 23 (25%) 1 (8.3%) 1 (9.1%)
Continuing hormone therapy 6 (20.7%) 21 (22.8%) 2 (16.7%) 1 (9.1%)
Watch	and	wait	/	Active	Surveillance 12 (13.0%) 2 (18.2%)
Other 1 (8.3%) 3 (27.3%)
Missing 1 (1.1%) 1 (8.3%)
(Continues)
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3  |  RESULTS
Sample characteristics are summarised in Table 1. Both cohorts 
had a higher proportion of patient (2019 n = 29 [70.73%]; 2020 
n = 92 [89.32%]) than support network participants (2019 n = 12 
[29.27%], 2020 n	 =	11	 [10.68%]).	Most	 participants	were	 female	
(n = 111, 77.1%), regardless of sub- sample. 2020 support network 
participants were significantly younger (p = .010) but age distribu-
tion	 is	generally	balanced	 (total	 sample:	M	=	55.84;	SD	=	10.65).	
The most prevalent diagnosis was breast cancer (n = 58, 40.3%). 
2019 participants were diagnosed significantly more recently: 
26 (63.4%) of the 2019 participants took part in the study within 
twelve months of diagnosis compared to 23 (22.3%) of 2020 par-
ticipants (p < 0.001). A significantly higher proportion of 2019 
respondents was receiving active anti- cancer treatment (n = 22 
[53.7%] cf. n = 29 [28.2%]; p = 0.002). The 2020 sample was sig-
nificantly	more	likely	to	have	visited	a	Maggie's	Centre	previously	
(n = 93 [90%] cf. n = 22 [54%] in 2019; p < 0.001) with 38% indicat-
ing at least weekly engagement.
The majority (n = 88, 95.7%) of the 2020 patient sample had not 
had	COVID-	19	symptoms,	nor	believed	they	had	been	exposed.	Half	
of these participants had been informed about unexpected changes to 
treatment and/or follow- up since pandemic onset. Of those who re-
sponded, 12 (21.4%) were unclear about the reason for changes, 21 
(40.4%) were unclear about the implications for treatment- related side- 
effects, 27 (52.9%) were unclear about impact on survival/prognosis, 
and 25 (47.2%) were unclear about whether changes were temporary.
3.1  |  Unmet needs
At domain level, patient needs were slightly lower after pandemic 
onset,	but	only	 the	difference	 in	 ‘Physical	and	Daily	Living	Needs’	
was significant (p	=	0.001).	Support	network	participants'	needs	re-
mained stable, with the exception of healthcare needs which were 
non- significantly elevated after pandemic onset (Table 2).
Four	of	the	five	patient	needs	that	were	most	reduced	fell	into	






For	 support	 networks,	 the	 five	most	 improved	 needs	 fell	 into	
‘Work	and	Social’	(3	items),	‘Information’	(1	item)	and	‘Psychological/
Emotional’	 (1	 item)	domains.	The	most	 increased	unmet	needs	 re-
lated	 to	 ‘Work	and	Social’	 (2	 items)	 and	 ‘Health	Care’	 (1	 item)	do-
mains, and two items which do not load onto a scoring domain (Girgis 
et al., 2011). The most increased unmet need related to contributing 
to	‘decision-	making	about	the	person	with	cancer's	treatment’.
3.2  |  Distress and QoL
Patients'	 anxiety	 was	 significantly	 lower	 after	 pandemic	 onset	
(p = 0.049), stress reduced slightly though non- significantly, and de-
pression	remained	the	same.	Overall	QoL	was	significantly	improved	
(p = 0.032), and physical and emotional sub- scales demonstrated 
large	and	medium	effect	size	differences	(Cohen's	d = 0.81 and 0.70, 
respectively).
Anxiety, depression and stress were all higher for support net-
work participants after pandemic onset, with depression approach-
ing statistical significance (p = 0.055). Differences in anxiety were 
associated	with	a	small	effect	size	(d = 0.37), differences in depres-
sion	were	associated	with	a	 large	effect	size	(d = 0.96) and differ-
ences	in	stress	were	associated	with	a	medium	effect	size	(d = 0.76). 
Mean	differences	must	be	greater	than	the	Reliable	Change	Index	
(RCI) to be considered reliable. In the current study, this criterion 
was met by the lower anxiety in the patient sample and higher de-
pression in the support network sample in 2020, as compared to 
2019. No other scales of the DASS were associated with reliable 
change.
Cancer patients Support Network
2019 (n = 29) 2020 (n = 92) p 2019 (n = 12) 2020 (n = 11) p
Use	of	Maggie's	Centres
New Visitor 12 (41.4%) 7 (7.6%) <0.001 7 (58.3%) 0.005




Weekly 26 (28.3%) 3 (27.3%)
Fortnightly 7 (7.6%) 2 (18.2%)
Monthly 23 (25.0%) 2 (18.2%)
<Monthly 17 (18.5%) 4 (36.4%)
Missing 9 (9.8%)
TABLE	1 (Continued)
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Overall	QoL	was	significantly	reduced	for	this	sample	(p = 0.009). 




This is the first study to comparatively quantify the psychosocial 
impact of COVID- 19 in cancer patients and those in their informal 
support	networks.	Half	of	our	patient	sample	 identified	significant	
changes to their cancer care, with confusion about the implications 
and temporal nature of such changes.
The current inferential analyses should be interpreted with cau-
tion	given	the	small	sample	size	of	this	study,	particularly	in	relation	
to our support network sample. Nevertheless, our data, which rely 
on comparison of psychometrically validated patient- reported out-
comes	prior	to,	and	during,	the	pandemic,	show	that	patients'	phys-
ical and daily living needs have been lower in 2020, as compared 
to	a	sample	of	participants	 recruited	 in	2019.	We	did	not	 find	 the	
greater	 distress	 and	 lower	QoL	 among	 cancer	 patients	 suggested	
elsewhere (Chen et al., 2020; Nekhlyudov et al., 2020). This may 
reflect the protective effect of engagement with psychosocial care 
services, however, that does not explain why overall need levels, nor 
support network well- being, failed to improve. Rather, well- being 
improvement likely stems from combined consequences of reduced 
intensity in face- to- face clinical care and physically demanding treat-
ments (Archer et al., 2020), alongside increased home- based infor-
mal care provision resulting from lockdown measures and shielding, 
and telehealth- delivered psychosocial care availability.
This	 is	 countered	 by	 the	 higher	 unmet	 needs	 in	 patients'	 sup-
port networks, which focus on family communication, practical 
caring tasks and accessing their own support. This group reported 
increased	anxiety,	stress,	depression	and	poorer	QoL	following	pan-
demic onset. The most reduced domain of unmet need relates to 
work and social settings (activities limited during lockdown) but ad-
ditional support in coping with the demands of home- based caring 
pressures is needed (Nekhlyudov et al., 2020).
Four	of	the	top	five	most	increased	patient	needs	related	to	hos-
pital care and access, reflecting the consequences of reduced face- 
to- face hospital attendance in view of SARS- Cov- 2 transmission risk 
(Tsamakis et al., 2020). Interestingly, support networks reported high 
unmet needs related to care co- ordination and treatment decision- 
making involvement, highlighting the broad- reaching consequences 
stemming from the discouragement of active hospital attendance.
4.1  |  Study limitations
Building on a number of non- empirical, commentary and opinion 
articles, this is the first systematic comparison of the impact of 
COVID- 19 on psychosocial outcomes in people affected by can-
cer. Though novel and multi- centre, there are design limitations: 
cross-	sectional	 studies	 lack	 sophistication,	 sample	 size	 is	 modest,	
and	our	2020	sample	had	longer	engagement	with	the	Maggie's	psy-
chosocial support programme. Given that there were some clinical 
and demographic differences between these two cohorts, we can-
not exclude the possibility that observed differences may be ex-
plained by factors unrelated to the pandemic. Some demographic 
and clinical groups were over- represented in both of our samples 
which may limit the generalisability of our findings to other popula-
tions. The small number of support network participants limits sta-
tistical	 power,	 however,	 the	medium-	to-	large	 effect	 sizes	 point	 to	
potentially clinically meaningful findings.
5  |  CONCLUSIONS
In conclusion, our study shows that the pandemic has led to re- 
adjustment of unmet needs across diverse domains of psychosocial 
well-	being.	 Despite	 not	 reporting	 poorer	 distress	 and	 QoL,	 can-
cer patients may be relying more on their own support networks 
to compensate for the lost availability of structured healthcare 
pathways. As social distancing and telemedicine continue to be 
promoted as public health strategies to protect the most vulner-
able	 from	COVID-	19,	 interventions	 to	support	cancer	patients'	 re-	
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